Skip to Content

India's Trade Crossroads: Navigating EU's CBAM, UK FTA Breakthroughs, and New PLI Schemes | Nov 2025 Analysis

29 November 2025 by
Himanshu Gupta
| No comments yet

India's Trade Crossroads: Navigating EU's CBAM, UK FTA Breakthroughs, and New PLI Schemes | Nov 2025 Analysis

By Sanskriti Global Exports by Himanshu Gupta

Navigating a Sea of Change: Key Trade Developments for India Inc.

Date: November 29, 2025

Good morning. As we move towards the close of 2025, the global trade landscape continues its dynamic evolution, presenting both formidable challenges and significant opportunities for Indian import-export professionals. Today’s roundup is particularly noteworthy, bringing critical updates from Brussels on carbon regulations, a major policy push from New Delhi to bolster high-tech manufacturing, a landmark development in the long-awaited India-UK trade pact, and a classic case of opportunity meeting operational friction in our pharmaceutical sector. For the astute professional, these are not just headlines; they are signposts demanding strategic attention and immediate action. Let’s dissect the day's key events and what they mean for your business.

Today's Factual Summary

The global and domestic trade wires have been buzzing with four pivotal stories that will shape the contours of Indian trade in the months to come.

First, the European Commission has announced an acceleration of its Carbon Border Adjustment Mechanism (CBAM) implementation. The transitional reporting phase, which has been in effect, will now conclude six months earlier than planned, with full financial implementation—meaning the purchase of CBAM certificates—to begin in Q3 2026. More critically, the EU has expanded the list of products under scrutiny, adding polymers and certain chemical precursors to the initial list of iron, steel, cement, aluminium, fertilisers, and electricity. This move signals Brussels' unwavering commitment to its Green Deal and places increased compliance pressure on its trading partners.

On the domestic front, the Government of India has unveiled a new, highly-anticipated phase of the Production Linked Incentive (PLI) scheme, squarely aimed at deepening India's capabilities in the high-technology value chain. Dubbed 'PLI for Core Components,' this phase targets critical sectors like semiconductor ATMP (Assembly, Testing, Marking, and Packaging), advanced chemistry cell batteries, and specialized solar PV components. The scheme offers robust incentives for companies, both domestic and international, that invest in setting up manufacturing facilities for these foundational goods, aiming to reduce import dependency and position India as a key node in resilient global supply chains.

In a significant diplomatic and economic breakthrough, negotiators have reportedly finalized key chapters of the India-UK Free Trade Agreement (FTA). Sources indicate that major consensus has been reached on contentious issues including rules of origin for automotive and textile products, intellectual property rights, and a framework for the movement of skilled professionals. While the final text is yet to be signed, this development strongly suggests that the comprehensive trade deal is on the verge of becoming a reality, promising to slash tariffs and open new avenues for services and goods trade between the two nations.

Finally, the Indian pharmaceutical sector is experiencing a massive surge in export orders, particularly for generic medicines, driven by a severe and prolonged influenza season across North America. While this demand spike is a testament to the strength of 'the pharmacy of the world,' it has created significant logistical bottlenecks. Major ports like Nhava Sheva and Mundra are reporting increased congestion and longer turnaround times for container vessels, putting pressure on supply chain timelines and threatening to delay critical shipments.

Implications for Indian Import-Export

These developments are not abstract policy shifts; they have direct, tangible consequences for your operations. Here is our analysis of the key takeaways and recommended actions:

  • CBAM Compliance is Now Mission-Critical: The EU’s accelerated timeline removes any room for complacency. For exporters of steel, aluminium, and now polymers and chemicals, this is a red alert.
    • Immediate Action: You must urgently invest in robust systems for measuring, verifying, and reporting the embedded carbon in your products. Waiting is no longer an option.
    • Strategic Advice: Begin exploring green technology upgrades for your manufacturing processes. Look into government subsidies for cleaner energy adoption. While diversifying markets is wise, achieving EU compliance should be seen as a long-term competitive advantage that will likely be replicated by other developed economies.
  • Seizing the High-Tech Manufacturing Opportunity: The new PLI scheme is a direct invitation to move up the value chain.
    • Immediate Action: If you operate in the electronics, automotive, or renewable energy sectors, conduct a thorough analysis of the new PLI criteria to assess eligibility. For component importers, this is a signal to aggressively pursue domestic sourcing partners.
    • Strategic Advice: This is a prime opportunity for joint ventures with global technology leaders seeking to de-risk their supply chains. The scheme not only provides financial incentives but also signals strong government backing, reducing investment risk.
  • Preparing for the UK Trade Windfall: The imminent FTA will rewrite the rules of engagement with a major market.
    • Immediate Action: Exporters in textiles, apparel, automotive parts, and IT services must begin proactively identifying UK clients and understanding the potential new tariff landscape. Logistics providers should start capacity planning for the India-UK corridor.
    • Strategic Advice: For importers, this is the time to scout for high-quality UK-made industrial machinery, technology, and premium consumer goods that will become more cost-competitive. The chapter on professional movement could be a game-changer for our services export sector.
  • Navigating the Pharma Logistics Crunch: The 'good problem' of high demand requires exceptional supply chain management.
    • Immediate Action: Pharmaceutical exporters must immediately communicate with their buyers about potential delays and build buffer time into all delivery schedules. Do not overpromise.
    • Strategic Advice: Actively engage with your freight forwarders to explore all options. This could mean booking vessel capacity far in advance, utilizing alternative, less-congested ports, or, for high-value and time-sensitive orders, strategically using air freight despite the higher cost. This situation is a real-world stress test of your supply chain's resilience.

Conclusion

The events of today perfectly encapsulate the dual reality of Indian trade in 2025. On one hand, we face increasing regulatory demands from key markets like the EU that require significant investment in compliance and sustainability. On the other, strategic government policy and successful trade negotiations are unlocking unprecedented opportunities in high-value manufacturing and established markets like the UK. The underlying lesson is clear: the businesses that will thrive are those that are agile, informed, and treat challenges like compliance and logistics not as mere operational hurdles, but as core components of their strategic planning. The path forward requires proactive investment, strategic partnerships, and a relentless focus on building resilient and intelligent supply chains.

Source: Original

in News
Himanshu Gupta 29 November 2025
Share this post
Our blogs
Sign in to leave a comment
India-UK FTA Nears Finish Line, DGFT Tightens Norms: A Trade Analysis for Nov 2025